Have a feature idea you'd love to see implemented?
Let us know!
LQDA Liquidia Corp
Price (delayed)
$11.23
Market cap
$862.39M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.57
Enterprise value
$818.17M
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT technology. The Company operates through two subsidiaries,
Highlights
LQDA's equity is down by 27% since the previous quarter but it is up by 3.4% year-on-year
The quick ratio is down by 23% QoQ but it is up by 19% YoY
The company's debt has surged by 137% YoY
LQDA's net income has plunged by 120% YoY and by 4.1% from the previous quarter
Key stats
What are the main financial stats of LQDA
Market
Valuations
Earnings
Shares outstanding
76.79M
Market cap
$862.39M
Enterprise value
$818.17M
Price to earnings (P/E)
N/A
Price to book (P/B)
13.68
Price to sales (P/S)
57.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
55.13
Revenue
$14.84M
EBIT
-$103.26M
EBITDA
-$100.73M
Free cash flow
-$77.67M
Per share
Balance sheet
Liquidity
EPS
-$1.57
Free cash flow per share
-$1.02
Book value per share
$0.82
Revenue per share
$0.19
TBVPS
$2.23
Total assets
$177.36M
Total liabilities
$114.64M
Debt
$88.87M
Equity
$62.72M
Working capital
$123.04M
Debt to equity
1.42
Current ratio
6.08
Quick ratio
5.63
Net debt/EBITDA
0.44
Margins
Efficiency
Dividend
EBITDA margin
-678.8%
Gross margin
69.5%
Net margin
-755.5%
Operating margin
-655.8%
Return on assets
-74.2%
Return on equity
-183.6%
Return on invested capital
-128.3%
Return on capital employed
-67.4%
Return on sales
-695.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LQDA stock price
How has the Liquidia stock price performed over time
Intraday
0.85%
1 week
1.91%
1 month
14.59%
1 year
82.31%
YTD
-6.65%
QTD
12.3%
Financial performance
How have Liquidia's revenue and profit performed over time
Revenue
$14.84M
Gross profit
$10.32M
Operating income
-$97.33M
Net income
-$112.11M
Gross margin
69.5%
Net margin
-755.5%
The company's net margin has shrunk by 164% YoY and by 12% QoQ
The company's operating margin has shrunk by 146% YoY and by 13% QoQ
LQDA's net income has plunged by 120% YoY and by 4.1% from the previous quarter
LQDA's operating income has dropped by 105% year-on-year and by 4.7% since the previous quarter
Growth
What is Liquidia's growth rate over time
Valuation
What is Liquidia stock price valuation
P/E
N/A
P/B
13.68
P/S
57.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
55.13
Liquidia's EPS has shrunk by 104% YoY
The stock's P/B is 94% above its 5-year quarterly average of 7.0 and 2.7% above its last 4 quarters average of 13.2
LQDA's equity is down by 27% since the previous quarter but it is up by 3.4% year-on-year
The stock's price to sales (P/S) is 63% more than its 5-year quarterly average of 35.1 and 15% more than its last 4 quarters average of 49.7
LQDA's revenue is down by 17% YoY and by 7% QoQ
Efficiency
How efficient is Liquidia business performance
The ROE has plunged by 196% YoY and by 3.3% from the previous quarter
Liquidia's return on sales has shrunk by 163% YoY and by 11% QoQ
The ROA has plunged by 87% YoY but it has grown by 5% from the previous quarter
The ROIC has contracted by 29% YoY but it has grown by 15% from the previous quarter
Dividends
What is LQDA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LQDA.
Financial health
How did Liquidia financials performed over time
The total assets is 55% more than the total liabilities
The company's total liabilities has surged by 88% YoY and by 3.4% QoQ
The total assets has grown by 46% YoY but it has contracted by 10% from the previous quarter
The company's debt is 42% higher than its equity
The company's debt has surged by 137% YoY
The debt to equity has soared by 129% YoY and by 39% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.